Gastroenterology News

Healio Gastroenterology is excited to announce the nominees for its annual Disruptive Innovators Awards in gastroenterology and hepatology.

The Federal Trade Commission proposal to ban noncompete clauses for all workers has sent powerful ripples through the health care industry, prompting physicians of all specialties to reevaluate their career trajectories.

Vedolizumab not only induced endoscopic improvements in patients with chronic pouchitis, but also appeared to improve clinical outcomes at week 34, especially in those who achieved mucosal healing at week 14, research showed.

Every August, gastrointestinal care providers and patient advocacy groups celebrate Gastroparesis Awareness Month, an annual campaign focused on improving understanding of gastroparesis and promoting preventive strategies.

CHICAGO — Adults with occasional constipation reported significant improvement in stool consistency and GI-related symptoms after receiving a probiotic blend, results from a randomized study presented at NUTRITION showed.

Health care providers know of the broad potential AI offers for reducing burnout, but which products are actually available for use can be difficult to ascertain, especially considering electronic health record system compatibility.

A triple therapy of vonoprazan, amoxicillin and bismuth potassium citrate achieved an eradication rate of just over 90%, similar to that of the standard quadruple therapy, in patients with Helicobacter pylori infection, according to data.

Skyrizi significantly improved clinical remission rates as both induction and maintenance therapy vs. placebo in patients with moderately to severely active ulcerative colitis, according to data from the phase 3 INSPIRE and COMMAND trials.

Individuals with unhealthy lifestyles may derive the most benefit from aspirin for colorectal cancer prevention, according to results of a prospective cohort study.

Completing at least one fecal immunochemical test screening correlated with a 33% overall lower risk for death from colorectal adenocarcinoma, with a 42% reduction reported for cancers in the left colon and rectum, according to researchers.